bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Oncternal Therapeutics Inc. logo

    Oncternal Therapeutics Inc.

    ONCT | NASDAQ
    Chart Builder DCF Calculator
    $0.53
    -$0.16 (-23.63%)
    At close: Dec 02, 2024, 04:00 PM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $1.56M
    Enterprise Value
    $-12.83M
    Beta
    1.36
    Average Volume
    N/A
    Shares Outstanding (Diluted)
    2.96M
    Shares Change YoY
    0.4%
    Institutional Ownership
    N/A
    Exchange
    N/A
    ISIN
    N/A

    Price Performance

    Price Change 1M
    N/A
    Price Change 3M
    N/A
    Price Change 6M
    N/A
    Price Change YTD
    N/A
    Price Change 1Y
    N/A
    Price Change 3Y
    N/A
    Price Change 5Y
    N/A
    1M CAGR (ann.)
    -53.8%
    1Y CAGR (ann.)
    -94.6%
    5Y CAGR (ann.)
    -64.0%
    All-Time CAGR
    -33.0%

    Valuation

    PE Ratio
    -0.05
    Forward PE
    N/A
    PEG Ratio
    -0.00
    Forward PEG
    -0.00
    PS Ratio
    0.93
    Forward PS
    1.60
    PB Ratio
    0.17
    P/FCF Ratio
    -0.06
    P/Adj. FCF Ratio
    -0.05
    P/OCF Ratio
    -0.05
    EV/Sales
    -7.70
    EV/EBIT
    0.36
    EV/EBITDA
    0.48
    EV/FCF
    0.48
    Earnings Yield
    -2205.7%
    FCF Yield
    -1708.8%
    Adj. FCF Yield
    -2146.0%

    Financial Health

    Net Cash
    $14.58M
    Total Debt
    $191K
    Cash & Short-Term Investments
    $14.58M
    Total Assets
    $15.6M
    Current Ratio
    6.94
    Quick Ratio
    6.94
    Debt / Equity Ratio
    0.01
    Debt / EBITDA
    -0.01
    Debt / FCF
    -0.01
    OCF / Debt
    -139.43
    Interest Coverage
    0.00
    Altman Z-Score
    -25.01
    Piotroski F-Score
    2

    Margins & Profitability

    Gross Profit Margin
    -3690.2%
    Operating Profit Margin
    -2157.1%
    EBITDA Margin
    284.7%
    Net Profit Margin
    -5029.2%
    FCF Margin
    -1597.6%
    Adj. FCF Margin
    -2006.4%
    SBC / Revenue
    955.4%
    SBC Impact (per share)
    -25.6%

    Returns

    Return on Assets
    -107.5%
    Return on Equity
    61.6%
    Return on Invested Capital
    -131.6%
    Return on Capital Employed
    -132.3%
    Return on Tangible Assets
    -107.5%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -32.2%
    Revenue CAGR 5Y
    -5.1%
    Revenue CAGR 10Y
    22.5%
    EPS CAGR 3Y
    -48.6%
    EPS CAGR 5Y
    -54.3%
    EPS CAGR 10Y
    15.0%
    FCF CAGR 3Y
    12.1%
    FCF CAGR 5Y
    -11.3%
    FCF CAGR 10Y
    -4.3%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    7
    EPS Growth Next 3Y
    N/A
    Revenue Growth Next 3Y
    N/A
    Earnings Date
    Nov 5, 2024
    EPS Estimate (next Q)
    -$3.22
    EPS Growth Est (next Q)
    -5.3%
    Revenue Est (next Q)
    $275K
    Revenue Growth Est (next Q)
    53.6%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $28
    Price Target Upside
    5183.0%

    Cash Flow

    Operating Cash Flow
    $-26.63M
    Free Cash Flow
    $-26.63M
    Adj. Free Cash Flow
    $-33.45M
    FCF Per Share
    -$10.94
    OCF Per Share
    -$10.94
    OCF/S Ratio
    -4097.3%

    Income Statement

    Revenue
    $1.67M
    Gross Profit
    $-16.96M
    Operating Income
    $-35.96M
    EBITDA
    $-26.74M
    Net Income
    $-34.58M
    EPS (Diluted)
    -$11.69
    Revenue / Employee
    N/A
    Profit / Employee
    N/A
    Employees
    N/A

    © 2026 bestshares.com. All rights reserved.